Analyst Ratings for AVEO Pharmaceuticals (aveo)
aveo Rating Summary
aveo Price Target Summary
- Highest: $16.00 (Canaccord Genuity)
- Lowest: $1.00 (BMO Capital)
- Average: $7.67
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$7.67 (+188.2%)
Avg. $ Target:
$7.67 (+188.2%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/3/2013 | Stifel Nicolaus | Upgrade | Hold (Sell) |
N/A (N/A) |
2.65 | 2.66 | 0.38% | Details |
| 5/3/2013 | RBC Capital | Downgrade | Sector Perform (Outperform) |
N/A (N/A) |
2.65 | 2.66 | 0.38% | Details |
| 5/2/2013 | William Blair | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
5.26 | 2.66 | -49.43% | Details |
| 5/2/2013 | JPMorgan | Downgrade | Neutral (Overweight) |
N/A (N/A) |
5.26 | 2.66 | -49.43% | Details |
| 5/2/2013 | BMO Capital | Downgrade | Underperform (Market Perform) |
1.00 (8.00) |
5.26 | 2.66 | -49.43% | Details |
| 4/2/2013 | JMP Securities | New Coverage | Market Perform (N/A) |
N/A (N/A) |
7.25 | 2.66 | -63.31% | Details |
| 10/8/2012 | Leerink Swann » Updated 4/30/2013 |
Downgrade | Market Perform (Outperform) |
N/A (N/A) |
9.99 | 2.66 | -73.37% | Details |
| 8/3/2012 | Jefferies » Updated 2/14/2013 |
Downgrade | Hold (Buy) |
6.00 (9.00) |
9.75 | 2.66 | -72.72% | Details |
| 4/30/2012 | Canaccord Genuity » Updated 8/3/2012 |
New Coverage | Buy (N/A) |
16.00 (N/A) |
11.25 | 2.66 | -76.36% | Details |
| 2/10/2012 | Morgan Stanley | New Coverage | Equalweight (N/A) |
N/A (N/A) |
14.26 | 2.66 | -81.35% | Details |
